Diagnostic tests can sometimes get to patients too late but technology is changing to treat patients early, particularly for respiratory problems and infectious diseases. Dr. Gian Han, director of Diatherex Laboratories, tells host Bruce Japsen about the diagnostic industry's progress in testing for respiratory diseases and superbugs via the latest in research and technology in molecular generics.
New Tests for Respiratory Diseases and Superbugs
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Diagnostic tests can sometimes get to patients too late but technology is changing to treat patients early, particularly for respiratory problems and infectious diseases. Dr. Gian Han, director of Diatherex Laboratories, tells host Bruce Japsen about the diagnostic industry's progress in testing for respiratory diseases and superbugs via the latest in research and technology in molecular generics.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?